MarketCap
Xtant Medical Holdings XTNT
$ 0.33
0.09%
Facebook
X
Telegram
Xtant Medical Holdings Gross Profit | XTNT
Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.
Calculation formula:Importance for business:
Gross Profit = Revenue – Cost of Goods Sold (COGS)
Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
- Raw materials and supplies
- Wages of production personnel
- Depreciation of equipment
- Transportation and warehousing costs (if directly related to production)
- Assessing core business profitability
If gross profit is declining, it may indicate rising production costs or falling sales. - Financial planning
Gross profit is the basis for calculating other key metrics, such as operating and net profit. - Benchmarking against competitors
Gross profit analysis helps compare the efficiency of different companies within the same industry. - Insights into pricing effectiveness
If gross profit is low, the company may be pricing too low or failing to control costs effectively.
- Increase in raw material and supply costs
- Rising production expenses
- Price reductions due to competition
- Decrease in sales volume
- Currency exchange rate fluctuations (for imports/exports)
Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.
Annual Gross Profit Xtant Medical Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 84.3 M | 68.2 M | 55.5 M | 32.1 M | 32.5 M | 34.4 M | 42.5 M | 43.5 M | 50.1 M | 62.3 M | 39.1 M | 22.3 M | 18.9 M | 22.6 M | 21 M | 12.1 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 84.3 M | 12.1 M | 40.1 M |
Quarterly Gross Profit Xtant Medical Holdings
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24.3 M | 12 M | - | 22 M | 24.3 M | 20.2 M | - | 16.3 M | 18.6 M | 17.3 M | - | 15.3 M | 12.5 M | 10.5 M | - | 7.9 M | 8.37 M | 7.56 M | - | 7.19 M | 9.52 M | 8.09 M | - | 9.25 M | 6.55 M | 9.61 M | - | 10.4 M | 9.91 M | 10.8 M | - | 11.5 M | 12.5 M | 12.2 M | - | 11.4 M | 13.5 M | 14.9 M | - | 16 M | 14.7 M | 14.1 M | - | 11.7 M | 6.52 M | 6.03 M | - | 5.44 M | 5.59 M | 5.5 M | - | 4.61 M | 4.69 M | 5.5 M | - | 6.28 M | 5.88 M | 5.91 M | - | 6.22 M | 5.77 M | 5.01 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 24.3 M | 4.61 M | 10.8 M |
Gross Profit of other stocks in the Medical devices industry
| Issuer | Gross Profit | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abbott Laboratories
ABT
|
18.7 B | $ 100.1 | 2.67 % | $ 174 B |  USA |
 |
Aethlon Medical
AEMD
|
1.36 M | $ 6.53 | 1.16 % | $ 4.4 M | USA |
 |
AdaptHealth Corp.
AHCO
|
89.3 M | $ 5.74 | 2.5 % | $ 776 M | USA |
 |
Align Technology
ALGN
|
2.71 B | $ 140.65 | 0.1 % | $ 10.2 B | USA |
 |
Apyx Medical Corporation
APYX
|
33 M | $ 2.6 | 1.96 % | $ 107 M | USA |
 |
Accuray Incorporated
ARAY
|
111 M | $ 0.3 | 7.37 % | $ 36.8 M | USA |
 |
Alphatec Holdings
ATEC
|
532 M | $ 10.72 | 6.88 % | $ 1.61 B | USA |
 |
AxoGen
AXGN
|
167 M | $ 37.22 | 0.21 % | $ 1.71 B | USA |
 |
Butterfly Network
BFLY
|
45.7 M | $ 9.38 | 4.8 % | $ 2.32 B | USA |
 |
Bio-Rad Laboratories
BIO
|
1.34 B | $ 379.82 | 2.89 % | $ 10.4 B | USA |
 |
Bruker Corporation
BRKR
|
1.58 B | $ 63.86 | 0.98 % | $ 9.69 B | USA |
 |
Boston Scientific Corporation
BSX
|
13.9 B | $ 42.4 | 0.31 % | $ 62.8 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
290 M | $ 8.77 | 0.34 % | $ 639 M |  Israel |
 |
ClearPoint Neuro
CLPT
|
22.7 M | $ 11.52 | 5.74 % | $ 326 M | USA |
 |
CONMED Corporation
CNMD
|
750 M | $ 47.33 | 2.25 % | $ 1.47 B | USA |
 |
Cytosorbents Corporation
CTSO
|
26.5 M | $ 3.97 | 0.12 % | $ 247 M | USA |
 |
Delcath Systems
DCTH
|
73.4 M | $ 15.87 | 4.89 % | $ 568 M | USA |
 |
Electromed
ELMD
|
57.9 M | $ 28.32 | 0.78 % | $ 234 M | USA |
 |
Establishment Labs Holdings
ESTA
|
146 M | $ 66.47 | 3.76 % | $ 1.97 B |  Costa-rica |
 |
Edwards Lifesciences Corporation
EW
|
4.73 B | $ 87.23 | 2.44 % | $ 51 B | USA |
 |
Globus Medical
GMED
|
1.02 B | $ 76.57 | 1.28 % | $ 10.4 B | USA |
 |
Helius Medical Technologies
HSDT
|
5.52 M | $ 2.65 | 0.76 % | $ 58.4 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
953 M | $ 13.29 | 4.81 % | $ 1.02 B | USA |
 |
Inogen
INGN
|
154 M | $ 5.94 | 0.34 % | $ 158 M | USA |
 |
InMode Ltd.
INMD
|
291 M | $ 14.13 | 0.28 % | $ 913 M | Israel |
 |
Inspire Medical Systems
INSP
|
779 M | $ 70.75 | 1.11 % | $ 2.08 B | USA |
 |
IRIDEX Corporation
IRIX
|
19.2 M | $ 0.69 | 7.28 % | $ 11.7 M | USA |
 |
IRadimed Corporation
IRMD
|
64.3 M | $ 86.47 | 1.25 % | $ 1.1 B | USA |
 |
Integer Holdings Corporation
ITGR
|
500 M | $ 126.45 | 0.1 % | $ 4.39 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
173 M | $ 22.89 | 3.29 % | $ 537 M | USA |
 |
LivaNova PLC
LIVN
|
940 M | $ 76.43 | 1.81 % | $ 4.17 B |  Britain |
|
LENSAR
LNSR
|
14.1 M | $ 6.67 | 0.59 % | $ 79.8 M | USA |
 |
Pulmonx Corporation
LUNG
|
67.1 M | $ 1.88 | 2.73 % | $ 76.5 M | USA |
 |
Medtronic PLC
MDT
|
19.6 B | $ 87.97 | 1.88 % | $ 113 B | USA |
 |
MiMedx Group
MDXG
|
346 M | $ 4.55 | 0.54 % | $ 672 M | USA |
 |
Myomo
MYO
|
26.9 M | $ 1.67 | 2.45 % | $ 69.9 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-12.8 M | $ 0.64 | 1.15 % | $ 41.5 M | Israel |
 |
InspireMD
NSPR
|
2.65 M | $ 0.58 | 1.64 % | $ 37.3 M | Israel |
 |
Orthofix Medical
OFIX
|
566 M | $ 9.5 | 4.51 % | $ 376 M |  Curacao |
 |
Outset Medical
OM
|
46.8 M | $ 4.1 | 3.54 % | $ 62.4 K | USA |
 |
PAVmed
PAVM
|
-85 K | $ 2.66 | 4.36 % | $ 1.78 M | USA |
 |
Penumbra
PEN
|
942 M | $ 317.11 | 0.07 % | $ 12.3 B | USA |
 |
Insulet Corporation
PODD
|
1.94 B | $ 135.62 | 2.98 % | $ 9.54 B | USA |
 |
Profound Medical Corp.
PROF
|
11.4 M | $ 6.03 | 3.25 % | $ 182 M |  Canada |
 |
Quanterix Corporation
QTRX
|
65 M | $ 3.81 | 4.67 % | $ 162 M | USA |
 |
AVITA Medical
RCEL
|
58.8 M | $ 13.25 | 4.17 % | $ 369 M |  Australia |
 |
Sintx Technologies
SINT
|
461 K | $ 2.18 | 1.05 % | $ 6.05 M | USA |
 |
Smith & Nephew plc
SNN
|
4.19 B | $ 26.92 | 1.87 % | $ 23.3 B | Britain |
 |
Sensus Healthcare
SRTS
|
11.9 M | $ 2.92 | 0.34 % | $ 47.7 M | USA |
 |
Stryker Corporation
SYK
|
4.63 B | $ 285.22 | 3.54 % | $ 109 B | USA |